-
1
-
-
0032926077
-
Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
-
DOI 10.1006/gyno.1998.5236
-
Schwartz PE, Rutherford TJ, Chambers JT, et al: Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol 1999; 72: 93-99. (Pubitemid 29045454)
-
(1999)
Gynecologic Oncology
, vol.72
, Issue.1
, pp. 93-99
-
-
Schwartz, P.E.1
Rutherford, T.J.2
Chambers, J.T.3
Kohorn, E.I.4
Thiel, R.P.5
-
2
-
-
0025947320
-
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer
-
Jacob JH, Gershenson DM, Morris M, et al: Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol 1991; 42: 146-150.
-
(1991)
Gynecol Oncol
, vol.42
, pp. 146-150
-
-
Jacob, J.H.1
Gershenson, D.M.2
Morris, M.3
-
3
-
-
0027327397
-
Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma
-
Lim JTW, Green JA: Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma. Clin Oncol (R Coll Radiol) 1993; 5: 198-202. (Pubitemid 23271093)
-
(1993)
Clinical Oncology
, vol.5
, Issue.4
, pp. 198-202
-
-
Lim, J.T.W.1
Green, J.A.2
-
4
-
-
0032422162
-
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
-
DOI 10.1006/gyno.1998.5213
-
Vergote I, De Wever I, Tjalma W, et al: Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 1998; 71: 431-436. (Pubitemid 29022333)
-
(1998)
Gynecologic Oncology
, vol.71
, Issue.3
, pp. 431-436
-
-
Vergote, I.1
De Wever, I.2
Tjalma, W.3
Van Gramberen, M.4
Decloedt, J.5
Van Dam, P.6
-
5
-
-
46749143864
-
Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery versus upfront surgery followed by chemotherapy (CT) in advanced epithelial ovarian carcinoma (EOC): A prospective randomized study - Interim results (abstract 5531)
-
Kumar L, Hariprasad R, Kumar S, et al: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery versus upfront surgery followed by chemotherapy (CT) in advanced epithelial ovarian carcinoma (EOC): a prospective randomized study - interim results (abstract 5531). J Clin Oncol 2007; 25: 18s.
-
(2007)
J Clin Oncol
, vol.25
-
-
Kumar, L.1
Hariprasad, R.2
Kumar, S.3
-
6
-
-
0035889879
-
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIC ovarian Carcinoma
-
DOI 10.1002/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#
-
Kuhn W, Rutke S, Späthe K, et al: Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 2001; 92: 2585-2591. (Pubitemid 33049442)
-
(2001)
Cancer
, vol.92
, Issue.10
, pp. 2585-2591
-
-
Kuhn, W.1
Rutke, S.2
Spaanthe, K.3
Schmalfeldt, B.4
Florack, G.5
Vonhundelshausen, B.6
Pachyn, D.7
Ulm, K.8
Graeff, H.9
-
7
-
-
0346423733
-
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
-
DOI 10.1056/NEJM199612263352603
-
Alberts DS, Liu PY, Hannigan EV, et al: Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996; 335: 1950-1955. (Pubitemid 26428219)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.26
, pp. 1950-1955
-
-
Alberts, D.S.1
Liu, P.Y.2
Hannigan, E.V.3
O'Toole, R.4
Williams, S.D.5
Young, J.A.6
Franklin, E.W.7
Clarke-Pearson, D.L.8
Malviya, V.K.9
DuBeshter, B.10
Adelson, M.D.11
Hoskins, W.J.12
-
8
-
-
0035865144
-
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the gynecologic oncology group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
-
Markman M, Bundy B, Alberts D, et al: Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately highdose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001; 19: 1001-1007. (Pubitemid 32176274)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.4
, pp. 1001-1007
-
-
Markman, M.1
Bundy, B.N.2
Alberts, D.S.3
Fowler, J.M.4
Clark-Pearson, D.L.5
Carson, L.F.6
Wadler, S.7
Sickel, J.8
-
9
-
-
30044438368
-
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
-
DOI 10.1056/NEJMoa052985
-
Armstrong DK, Bundy B, Wenzel L, et al: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43. (Pubitemid 43048949)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.1
, pp. 34-43
-
-
Armstrong, D.K.1
Bundy, B.2
Wenzel, L.3
Huang, H.Q.4
Baergen, R.5
Lele, S.6
Copeland, L.J.7
Walker, J.L.8
Burger, R.A.9
Mackey, D.10
-
10
-
-
60449103699
-
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009
-
Tiersten AD, Liu PY, Smith HO, et al: Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009. Gynecol Oncol 2009; 112: 444-449.
-
(2009)
Gynecol Oncol
, vol.112
, pp. 444-449
-
-
Tiersten, A.D.1
Liu, P.Y.2
Smith, H.O.3
-
11
-
-
0002858680
-
In vitro determination of drug response: A discussion of clinical applications
-
Fruehauf JP, Bosanquet AG: In vitro determination of drug response: a discussion of clinical applications. PPO Updates 1993; 12: 1-10.
-
(1993)
PPO Updates
, vol.12
, pp. 1-10
-
-
Fruehauf, J.P.1
Bosanquet, A.G.2
-
12
-
-
77950916028
-
Extreme drug resistance (EDR): Assay to cisplatinum and survival in ovarian cancer patients - A comparative analysis
-
abstract 1579
-
Fruehauf JP, Saha S, Mehta RS, et al: Extreme drug resistance (EDR): assay to cisplatinum and survival in ovarian cancer patients - a comparative analysis. Program and Abstracts Am Soc Clin Oncol 36th Annu Meet, New Orleans, 2000, abstract 1579.
-
(2000)
Program and Abstracts Am Soc Clin Oncol 36th Annu Meet, New Orleans
-
-
Fruehauf, J.P.1
Saha, S.2
Mehta, R.S.3
-
13
-
-
0036919813
-
Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients
-
Holloway RW, Mehta RS, Finkler NJ, et al: Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol 2002; 87: 8-16.
-
(2002)
Gynecol Oncol
, vol.87
, pp. 8-16
-
-
Holloway, R.W.1
Mehta, R.S.2
Finkler, N.J.3
-
14
-
-
23844494391
-
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma
-
DOI 10.1016/j.ygyno.2005.04.036, PII S0090825805003124
-
Tewari K, Mehta RS, Burger RA, et al: Conservation of in vitro drug resistance profiles in epithelial ovarian cancer. Gynecol Oncol 2005; 98: 360-368. (Pubitemid 41169145)
-
(2005)
Gynecologic Oncology
, vol.98
, Issue.3
, pp. 360-368
-
-
Tewari, K.S.1
Mehta, R.S.2
Burger, R.A.3
Yu, I.-R.4
Kyshtoobayeva, A.S.5
Monk, B.J.6
Manetta, A.7
Berman, M.L.8
Disaia, P.J.9
Fruehauf, J.P.10
-
15
-
-
0347381373
-
Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy
-
DOI 10.1067/S0002-9378(03)00629-X
-
Loizzi V, Chan JK, Osann K, et al: Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol 2003; 189: 1301-1307. (Pubitemid 37542162)
-
(2003)
American Journal of Obstetrics and Gynecology
, vol.189
, Issue.5
, pp. 1301-1307
-
-
Loizzi, V.1
Chan, J.K.2
Osann, K.3
Cappuccini, F.4
DiSaia, P.J.5
Berman, M.L.6
|